subscribeSubscribe
EMA’s CHMP Rejects Another Drug Approved by US FDA

EMA’s CHMP Rejects Another Drug Approved by US FDA
Zachary Brennan RAPS
01 Jul 2019
Share Share
EMA’s CHMP Offers Negative Opinion for Sickle Cell Drug Approved by US FDA

EMA’s CHMP Offers Negative Opinion for Sickle Cell Drug Approved by US FDA
Zachary Brennan RAPS
30 May 2019
Share Share
EMA Sees Spike in Medicines Recommendations in 2018

EMA Sees Spike in Medicines Recommendations in 2018
Michael Mezher RAPS
05 Jan 2019
Share Share
Actinium Appoints Robert N. Daly, Ph.D. as VP, Head of Clinical Operations

Actinium Appoints Robert N. Daly, Ph.D. as VP, Head of Clinical Operations
PR NEWSWIRE
06 Sep 2018
Share Share
J&J, Bayer fail at IInd attempt to spotlight safe benefit for Xarelto in VTE

J&J, Bayer fail at IInd attempt to spotlight safe benefit for Xarelto in VTE
John Carroll ENDPTS
27 Aug 2018
Share Share
Meeting highlights from the CHMP 23-26 July 2018

Meeting highlights from the CHMP 23-26 July 2018
EMA
31 Jul 2018
Share Share
Six medicines recommended for approval, including one orphan

Six medicines recommended for approval, including one orphan
EMA
24 Mar 2018
Share Share
EMA’s CHMP Rejects Two Drugs Approved by US FDA in 2017

EMA’s CHMP Rejects Two Drugs Approved by US FDA in 2017
Z. Brennan RAPS
24 Mar 2018
Share Share
Helsinn buys global rights for skin cancer drug from Actelion; Akebia reels in more cash for vadadustat; EMA slams Bevyxxa

Helsinn buys global rights for skin cancer drug from Actelion; Akebia reels in more cash for vadadustat; EMA slams Bevyxxa
B. Meiling ENDPTS
23 Mar 2018
Share Share
Portola Pharmaceuticals: What The Early FDA Approval Of Bevyxxa PAS Entails

Portola Pharmaceuticals: What The Early FDA Approval Of Bevyxxa PAS Entails
SEEKINGALPHA
21 Dec 2017
Share Share